Medicale Growth Metrics (2021-2025) | MCLE

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 8.44%-74.37%-98.74%-98.22%-97.96%0.00%0.00%0.00%0.00%0.00%
Assets Growth (3y) -76.07%-83.42%-82.22%-76.71%
Assets (QoQ) 200.86%-55.51%-28.90%-12.79%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Cash & Equivalents Growth (1y) -98.56%-95.29%-53.78%0.00%0.00%0.00%0.00%0.00%
Cash & Equivalents Growth (3y) -81.19%-80.29%-79.51%-63.90%
Cash & Equivalents (QoQ) -13.09%-11.06%-81.71%-89.82%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Cash from Operations Growth (1y) -90.75%15.10%11.52%-20.60%101.05%-78.52%-180.85%-244.40%-17,525.16%-473.68%-12.72%-26.71%63.91%85.43%78.24%58.37%
Cash from Operations Growth (3y) -51.84%-105.63%-40.96%-73.94%12.83%-14.28%11.68%-22.02%
Cash from Operations (QoQ) 54.83%7.24%11.13%-412.25%79.90%3.33%-21.13%104.47%-3,507.55%-52.09%-48.54%-126.36%-12.19%70.12%-66.98%35.52%54.70%55.39%-219.50%
EBIT Growth (1y) -57.17%15.89%11.31%-110.08%51.85%-1.33%-39.18%-3.44%-121.56%-73.39%-8.80%-9.01%40.88%61.51%44.20%
EBIT Growth (3y) -18.80%-13.90%-10.33%-33.31%-1.28%16.47%14.31%
EBIT (QoQ) 37.68%3.61%5.34%-176.40%66.65%-1.64%-124.23%36.64%29.83%-39.61%-66.65%-35.71%45.08%12.40%-66.98%42.97%-142.07%
EBT Growth (1y) -57.17%15.89%11.31%-110.08%51.85%-1.33%-39.18%-3.44%-121.56%-89.11%-22.54%-18.65%44.41%65.83%48.74%
EBT Growth (3y) -18.80%-17.25%-14.79%-37.13%-2.13%16.47%14.31%
EBT (QoQ) 37.68%3.61%5.34%-176.40%66.65%-1.64%-124.23%36.64%29.83%-39.61%-66.65%-35.71%40.10%9.54%-61.37%44.38%-142.07%
Enterprise Value Growth (1y) 98.56%95.29%53.78%0.00%0.00%0.00%0.00%0.00%
Enterprise Value Growth (3y) 81.19%80.29%79.51%63.90%
Enterprise Value (QoQ) 13.09%11.06%81.71%89.82%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EPS (Basic) Growth (1y) 97.01%93.95%91.32%94.40%175.83%
EPS (Basic) Growth (3y) -120.45%-81.29%
EPS (Basic) (QoQ) 50.54%30.26%-55.00%94.40%0.00%0.00%0.00%175.83%44.38%
EPS (Weighted Average and Diluted) Growth (1y) 91.32%94.40%175.83%
EPS (Weighted Average and Diluted) Growth (3y) -120.45%-81.29%
EPS (Weighted Average and Diluted) (QoQ) -55.00%94.40%0.00%0.00%0.00%175.83%44.38%
Free Cash Flow Growth (1y) -90.75%15.10%11.52%-20.60%101.05%-78.52%-180.85%-244.40%-17,525.16%-473.68%-12.72%-26.71%63.91%85.43%78.24%58.37%
Free Cash Flow Growth (3y) -51.84%-105.63%-40.96%-73.94%12.83%-14.28%11.68%-22.02%
Free Cash Flow (QoQ) 54.83%7.24%11.13%-412.25%79.90%3.33%-21.13%104.47%-3,507.55%-52.09%-48.54%-126.36%-12.19%70.12%-66.98%35.52%54.70%55.39%-219.50%
Net Cash Flow Growth (1y) -112.70%89.00%136.94%-78.52%
Net Cash Flow Growth (3y) 62.58%
Net Cash Flow (QoQ) -113.09%26.57%-557.21%79.90%88.67%-197.15%
Net Income Growth (1y) 94.79%91.64%91.32%90.84%175.83%
Net Income Growth (3y) -120.45%-81.29%-143.42%
Net Income (QoQ) 37.68%3.61%5.34%90.84%0.00%0.00%0.00%175.83%44.38%-142.07%
Net Income towards Common Stockholders Growth (1y) 94.79%91.64%91.32%90.84%175.83%
Net Income towards Common Stockholders Growth (3y) -120.45%-81.29%-143.42%
Net Income towards Common Stockholders (QoQ) 37.68%3.61%5.34%90.84%0.00%0.00%0.00%175.83%44.38%-142.07%
Operating Income Growth (1y) -57.17%15.89%11.31%-110.08%51.85%-1.33%-39.18%-3.44%-121.56%-73.39%-8.80%-9.01%40.88%61.51%44.20%
Operating Income Growth (3y) -18.80%-13.90%-10.33%-33.31%-1.28%16.47%14.31%
Operating Income (QoQ) 37.68%3.61%5.34%-176.40%66.65%-1.64%-124.23%36.64%29.83%-39.61%-66.65%-35.71%45.08%12.40%-66.98%42.97%-142.07%
Profit After Tax Growth (1y) -62.38%7.53%2.63%-119.25%53.39%7.84%-26.77%0.88%-121.56%-89.11%-22.54%-18.65%28.44%47.16%36.79%
Profit After Tax Growth (3y) -18.80%-17.25%-14.79%-37.13%-7.64%6.37%9.41%
Profit After Tax (QoQ) 37.68%3.61%5.34%-185.57%64.51%-1.49%-113.16%39.29%29.83%-39.61%-66.65%-35.71%40.10%9.54%-61.37%33.20%-93.02%
Return on Assets Growth (1y) -332.009.00
Return on Assets (QoQ) -32.0037.00377.00377.00
Return on Capital Employed Growth (1y) 75.0048.00218.00242.00264.00
Return on Capital Employed (QoQ) -84.00-26.00-53.00-48.00315.004.00-29.00-26.00
Return on Equity Growth (1y) -628.00-116.00-43.00-22.00-6.00
Return on Equity Growth (3y) -43.00-15.00
Return on Equity (QoQ) -513.00-72.00-26.00-17.00-1.001.00-4.00-2.003.00
Return on Sales (QoQ) 2,248.005,443.00
Shareholder's Equity Growth (1y) -109.42%-759.48%-2,135.62%-555.58%56.23%46.70%34.46%25.66%-406.94%-298.70%-209.71%-142.96%-92.60%-73.05%-57.72%
Shareholder's Equity Growth (3y) -66.88%-152.07%-256.69%-127.93%-62.28%-54.36%-47.39%
Shareholder's Equity (QoQ) 139.54%-135.40%-362.11%-223.77%-24.53%-19.99%-35.51%78.38%-51.64%-47.54%-53.70%-47.41%-19.26%-14.61%-20.57%-16.86%-7.16%-4.46%
Total Debt Growth (1y) 190.75%232.29%52.83%-42.39%
Total Debt (QoQ) 75.00%-50.00%100.00%22.27%24.99%